In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson’s disease

See Gratwicke and Foltynie (doi:10.1093/brain/awx333) for a scientific commentary on this article. Cognitive impairments are a prevalent and disabling non-motor complication of Parkinson’s disease, but with variable expression and progression. The onset of serious cognitive decline occurs alongside...

Descripción completa

Detalles Bibliográficos
Autores principales: Ray, Nicola J, Bradburn, Steven, Murgatroyd, Christopher, Toseeb, Umar, Mir, Pablo, Kountouriotis, George K, Teipel, Stefan J, Grothe, Michel J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837422/
https://www.ncbi.nlm.nih.gov/pubmed/29228203
http://dx.doi.org/10.1093/brain/awx310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837422/
https://www.ncbi.nlm.nih.gov/pubmed/29228203
http://dx.doi.org/10.1093/brain/awx310

Ejemplares similares